Abstracts tagged "patient preferences"

Abstract Number: 447 • 2016 ACR/ARHP Annual Meeting
The Influence of Risk Presentation Format on Willingness to Start a Medication
Raluca Cozmuta¹, Evan Wilhelms², Valerie Reyna³, Julia Nolte³ and Liana Fraenkel⁴, ¹Emory University School of Medicine, Atlanta, GA, ²Vasser College, Poughkeepsie, NY, ³Cornell University, Ithica, NY, ⁴Yale University School of Medicine, New Haven, CT
Background/Purpose: Patients with rheumatoid arthritis frequently refuse to escalate care because they overweight the probability of adverse events. Effectively communicating risk information to patients is…
Abstract Number: 455 • 2016 ACR/ARHP Annual Meeting
Validity, Reliability and Sensitivity to Change of Four Different Patient-Reported Outcomes (PROs) to Measure the Domains Pain, Fatigue, Experienced Disease Activity and General Well-Being in Patients with Rheumatoid Arthritis
Lisanne Renskers¹, Piet L.C.M. van Riel^2,3 and Ron J.J.C. van Uden¹, ¹IQ healthcare, Radboud university medical center, Radboud Institute for Health Sciences, IQ healthcare, Nijmegen, Netherlands, ²Radboud university medical center, Radboud Institute for Health Sciences, IQ healthcare, Nijmegen, Netherlands, ³Bernhoven, Department of Rheumatology, Uden, Netherlands
Background/Purpose: With Patient-Reported Outcomes (PROs), the patient's perspective can be assessed. Several forms can be used; Verbal Rating Scale (VRS), Numerical Rating Scale (NRS), Visual…
Abstract Number: 2084 • 2016 ACR/ARHP Annual Meeting
Effects of a Web-Based Patient Decision Aid on Biologics for Rheumatoid Arthritis: A Proof-of-Concept Study
Linda Li¹, Chris Shaw², Diane Lacaille¹, Elaine Yacyshyn³, C. Allyson Jones⁴, Paul Adam⁵, Cheryl Koehn⁶, Alison Hoens⁷, Jasmina Geldman⁸, Charles Goldsmith⁹, Eric C. Sayre⁸ and Nick Bansback¹⁰, ¹Rheumatology, Arthritis Research Canada, Richmond, BC, Canada, ²School of Interactive Arts and Technology, Simon Fraser University, Surrey, BC, Canada, ³University of Alberta, Edmonton, AB, Canada, ⁴Physical Therapy, University of Alberta, Edmonton, AB, Canada, ⁵Mary Pack Arthritis Program, Vancouver, BC, Canada, ⁶Arthritis Consumer Experts, Vancouver, BC, Canada, ⁷Dept of Physical Therapy, University of British Columbia, Vancouver, BC, Canada, ⁸Arthritis Research Canada, Richmond, BC, Canada, ⁹Faculty of Health Sciences, Simon Fraser University, Vancouver, BC, Canada, ¹⁰School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada
Background/Purpose : Under the treat-to-target approach for patients with rheumatoid arthritis (RA), a biologic agent is considered when the target is not met despite trying…
Abstract Number: 2649 • 2016 ACR/ARHP Annual Meeting
Patient Preferences Regarding Rheumatoid Arthritis Therapies in Lebanon: Results from a National, Multicenter, Cross-Sectional Survey
Fouad Fayad¹, Nelly Ziade², Georges Merheb^3,4, Said Attoui⁵, Alla Aiko⁶, Kamel Mroue⁵ and Abdel Fattah Masri⁷, ¹Hotel Dieu de France Hospital and Saint Joseph University, Beirut, Lebanon, ²Rheumatology, Hotel Dieu de France Hospital and Saint Joseph University, Beirut, Lebanon, ³Internal Medicine, Notre Dame des Secours University Hospital, Jbeil, Lebanon, ⁴Holly Spirit University, Kaslik, Lebanon, ⁵Hammoud University Medical Center, Saida, Lebanon, ⁶Saint Georges Hospital, Beirut, Lebanon, ⁷American University of Beirut Medical Center, Beirut, Lebanon
Background/Purpose: Treatment options in rheumatoid arthritis (RA) have expanded significantly over recent years, and several agents are now available for oral, subcutaneous (SC) or intravenous…
Abstract Number: 2480 • 2015 ACR/ARHP Annual Meeting
The Impact of Emotional Trade-Off Difficulty on Choice
Raluca Cozmuta¹, Sonal Bhalla² and Liana Fraenkel³, ¹Rheumatology, Yale University School of Medicine, New Haven, CT, ²Yale University School of Medicine, New Haven, CT, ³Medicine, Yale University School of Medicine, New Haven, CT
Background/Purpose: Patients' preferences for competing treatment options can be measured using stated preference methods which require subjects to make trade-off between specific attributes. Responses can…
Abstract Number: 2544 • 2015 ACR/ARHP Annual Meeting
Representing the Variability in Patients’ Preferences
Raluca Cozmuta¹, Sonal Bhalla² and Liana Fraenkel³, ¹Rheumatology, Yale University School of Medicine, New Haven, CT, ²Yale University School of Medicine, New Haven, CT, ³Medicine, Yale University School of Medicine, New Haven, CT
Background/Purpose: Data describing patients' priorities, concerns, and preferences are essential to inform important decisions in health care, including treatment planning and the development of programs…
Abstract Number: 2629 • 2015 ACR/ARHP Annual Meeting
The Most Frequent Fears and Beliefs of 226 Patients with Rheumatoid Arthritis or Spondyloarthritis, Using a Novel Questionnaire
Laure Gossec^1,2, Pierre Chauvin^3,4, Christophe Hudry⁵, Florence Mathoret-Philibert⁶, Maud Poussière⁷, Thibault de Chalus⁸, Francoise Russo-Marie⁹, Jean-Michel Joubert⁸, Alain Saraux¹⁰ and Francis Berenbaum^1,11, ¹Rheumatology Department, Sorbonne Universités, Université Pierre et Marie Curie, Paris, France, ²Rheumatology Department, AP-HP, Hôpital Pitié Salpêtrière, Paris, France, ³Department of Social Epidemiology, Sorbonne Universités, Université Pierre et Marie Curie, Paris, France, ⁴Department of Social Epidemiology, Pierre Louis Institute of Epidemiology and Public Health, Paris, France, ⁵Rheumatology, AP-HP, Hôpital Cochin, Paris, France, ⁶Clinical Psychology Department, AP-HP, Hôpital Cochin, Paris, France, ⁷Independent Researcher, Paris, France, ⁸UCB Pharma, Colombes, France, ⁹Arthritis Foundation Courtin, Neuilly-sur-Seine, France, ¹⁰Rheumatology Department, CHU de la Cavale Blanche, Brest Cedex, France, ¹¹Rheumatology Department, AP-HP, Hôpital Saint-Antoine, Paris, France
Background/Purpose: Patients with chronic inflammatory disorders such as rheumatoid arthritis (RA) or spondyloarthritis (SpA) create personal sets of fears and beliefs related to their disease.…
Abstract Number: 2632 • 2015 ACR/ARHP Annual Meeting
Development and Validation of a Questionnaire Assessing the Fears and Beliefs of Patients Suffering from Chronic Rheumatic Diseases
Laure Gossec^1,2, Alain Saraux³, Christophe Hudry⁴, Florence Mathoret-Philibert⁵, Maud Poussière⁶, Thibault de Chalus⁷, Francoise Russo-Marie⁸, Jean-Michel Joubert⁷, Pierre Chauvin⁹ and Francis Berenbaum^1,10, ¹Rheumatology Department, Sorbonne Universités, Université Pierre et Marie Curie, Paris, France, ²Rheumatology Department, AP-HP, Hôpital Pitié Salpêtrière, Paris, France, ³Rheumatology Department, CHU de la Cavale Blanche, Brest Cedex, France, ⁴Rheumatology, AP-HP, Hôpital Cochin, Paris, France, ⁵Clinical Psychology Department, AP-HP, Hôpital Cochin, Paris, France, ⁶Independent Researcher, Paris, France, ⁷UCB Pharma, Colombes, France, ⁸Arthritis Foundation Courtin, Neuilly-sur-Seine, France, ⁹Department of Social Epidemiology, Sorbonne Universités, Université Pierre et Marie Curie, Paris, France, ¹⁰Rheumatology Department, Hôpital Saint-Antoine, Paris, France
Background/Purpose: Questionnaires assessing the beliefs of patients with chronic rheumatic diseases mainly focus on medications.1A validated questionnaire evaluating patients' fears and beliefs towards their disease…
Abstract Number: 429 • 2015 ACR/ARHP Annual Meeting
Treatment Preferences of Patients with Early Rheumatoid Arthritis: A Discrete-Choice Experiment
Glen S. Hazlewood^1,2, Claire Bombardier³, George A. Tomlinson⁴, Carter Thorne⁵, VP Bykerk⁶, Andrew Thompson⁷, Diane Tin⁸ and Deborah Marshall⁹, ¹Medicine, University of Calgary, Calgary, AB, Canada, ²Institute of Health, Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada, ³Division of Rheumatology and Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada, ⁴Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada, ⁵Southlake Regional Health Centre, Newmarket, ON, Canada, ⁶Rheumatology, Hospital for Special Surgery, New York, NY, ⁷Rheumatology, St Joseph's Hlth Ctr, London, ON, Canada, ⁸The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, ⁹University of Calgary, Calgary, AB, Canada
Background/Purpose: Treatment choices in early rheumatoid arthritis need to balance benefits, risks, and other considerations such as dosing and monitoring. The objective of this study…
Abstract Number: 1044 • 2015 ACR/ARHP Annual Meeting
Many Patients with Early Rheumatoid Arthritis Want Triple Therapy: An Analysis Combining Comparative Effectiveness Research and Patients Preferences to Inform Treatment Recommendations
Glen S. Hazlewood^1,2, Claire Bombardier³, George A. Tomlinson⁴ and Deborah Marshall⁵, ¹Institute of Health, Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada, ²Medicine, University of Calgary, Calgary, AB, Canada, ³Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada, ⁴Medicine, University Health Network, Toronto, ON, Canada, ⁵University of Calgary, Calgary, AB, Canada
Background/Purpose: Growing evidence supports the efficacy of triple therapy (methotrexate + sulphasalazine + hydroxychloroquine) for controlling disease activity in patients with early rheumatoid arthritis (ERA),…
Abstract Number: 2478 • 2015 ACR/ARHP Annual Meeting
Does Affect Predict Willingness to Take Medication?
Liana Fraenkel¹, Marilyn Stolar², Richard L. Street Jr.³, Harjinder Chowdhary² and Ellen Peters⁴, ¹Medicine, Yale University School of Medicine, New Haven, CT, ²Yale University, New Haven, CT, ³Department of Communication, Texas A&M University, College Station, TX, ⁴Ohio State University, Columbus, OH
Does Affect Predict Willingness to Take Medication?Background/Purpose: Affect is known to have a significant impact on judgment and decision making. The data supporting this finding,…
Abstract Number: 2441 • 2014 ACR/ARHP Annual Meeting
Prevalence and Determinants of Treatment Adherence Among Patients with Rheumatoid Arthritis
Maria Celeste Orozco¹, Maria Florencia Marengo², Christian A. Waimann², Ana Inés Marcos³, Amelia Granel³, Sofia Velez⁴, Federico Zazzetti⁵, Juan C. Barreira⁶, Paula Kohan⁷, Oscar L. Rillo⁸, María Victoria Collado⁹, Graciela Gómez¹⁰, Ricardo V. Juárez¹¹, Veronica Lencina¹², Andrea D'Orazio¹³, Gustavo Rodriguez Gil¹³, Mariana Salcedo¹⁴ and Gustavo Citera¹⁵, ¹Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ²Rheumatology section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ³Rheumatology, Hospital San Roque de Gonnet, La Plata, La Plata, Argentina, ⁴Rheumatology, Hospital Britanico, Buenos Aires, Argentina, ⁵Hospital Britanico, Buenos Aires, Argentina, ⁶Rheumatology, British Hospital, Buenos Aires, Argentina, ⁷rheumatology, Hospital Gral. de agudos Dr. E. Tornú, Buenos Aires, Argentina, ⁸Rheumatology Unit, Hospital General de Agudos Dr. E. Tornú, Buenos Aires, Argentina, ⁹Instituto de Investigaciones Medicas Alfredo Lanari, Buenos Aires, Argentina, ¹⁰Diaz Colodrero 2537 8° A, Insituto de Investigaciones Medicas de la UBA, Capital Federal, Argentina, ¹¹Rheumatology Section, Hospital Señor del Milagro, Salta, Argentina, ¹²Rheumatology section, Hospital Señor del Milagro, Salta, Argentina, ¹³rheumatology, Hospital Municipal de agudos Dr. Leonidas Lucero, Bahía Blanca, Argentina, ¹⁴Consultorio Privado, San Nicolás, Argentina, ¹⁵Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina
Background/Purpose : Treatment adherence is a crucial part of successfully managing rheumatic diseases such as Rheumatoid Arthritis (RA). Low adherence to treatment has been related…
Abstract Number: 1907 • 2013 ACR/ARHP Annual Meeting
Acceptability Of Various Technology-Based Communication Modalities In a Rheumatology Clinic
Lisa A. Davis^1,2,3, Phat Luong¹, Sushmitha Bobba⁴, Hannah Dischinger¹, Itziar Quinzanos^4,5,6 and Liron Caplan^4,7, ¹Denver Veterans Affairs Medical Center, Denver, CO, ²Division of Rheumatology, Denver Health and Hospital Authority, Denver, CO, ³Division of Rheumatology, Univ. of Colorado Sch. of Medicine, Aurora, CO, ⁴Department of Medicine, Denver Veterans Affairs Medical Center, Denver, CO, ⁵Department of Medicine, Division of Rheumatology, Denver Health and Hospital Authority, Denver, CO, ⁶Department of Medicine, Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, ⁷Department of Medicine, University of Colorado School of Medicine, Aurora, CO
Background/Purpose: Technological advances have diversified the communication modalities of patients and healthcare providers. These include conveying information through telephone, internet portals, short-message service (SMS, “texting”),…
Abstract Number: 1346 • 2013 ACR/ARHP Annual Meeting
Drug Free Holiday In Patients With Rheumatoid Arthritis (RA): patients’ Opinion
I.M. Markusse, G. Akdemir, T.W.J. Huizinga and C.F. Allaart, Rheumatology, Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: Clinical trials have shown that in many patients tapering and/or stopping antirheumatic medication is a realistic option. We interviewed patients to investigate their opinions,…
Abstract Number: 2405 • 2012 ACR/ARHP Annual Meeting
A Proof-of-Concept Study of an Animated, Web-Based Methotrexate Decision Aid for Patients with Rheumatoid Arthritis
Linda C. Li¹, Paul M. Adam², Catherine L. Backman³, Sydney Brooks⁴, Gwen A. Ellert⁵, Allyson Jones⁶, Otto Kamensek⁷, Cheryl Koehn⁸, Diane Lacaille⁷, Colleen Maloney⁷, Anne F. Townsend⁹, Elaine Yacyshyn¹⁰, Charlene Yousefi⁷ and Dawn Stacey¹¹, ¹Department of Physical Therapy, University of British Columbia, Vancouver, BC, Canada, ²Rheumatology Liaison, Mary Pack Arthritis Centre, Vancouver, BC, Canada, ³Occupational Science & Occupational Therapy, The University of British Columbia, Vancouver, BC, Canada, ⁴The Arthritis Society, Ontario Division, Toronto, ON, Canada, ⁵Health Education, Trelle Enterprises Inc, Vancouver, BC, Canada, ⁶Department of Physical Therapy, University of Alberta, Edmonton, AB, Canada, ⁷Arthritis Research Centre of Canada, Vancouver, BC, Canada, ⁸Arthritis Consumer Experts, Vancouver, BC, Canada, ⁹Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, ¹⁰562 Heritage Med Rsch Ctr, University of Alberta, Edmonton, AB, Canada, ¹¹School of Nursing, University of Ottawa, Ottawa, ON, Canada
Background/Purpose: Patient decision aids are designed to present the potential benefits and harm of treatment options, clarify individuals’ preferences, and guide discussion at a clinic…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].